Allergic Reactions (Moderate Risk) 5-10% users mild allergic reactions
These medications mimic the glucagon-like peptide-1 (GLP-1) hormone, which naturally helps control appetite, slow digestion, and regulate insulin response
The FDA has indicated it will not enforce these legislative limits until after a new version of the MOU has been published in the Federal Register
Building a supportive environment, the clients and places that keep you moving forward Change is easier with support
At the same time, however, a weekly injection of either Mounjaro or Ozempic might cause temporary abdominal pain, constipation, diarrhea, nausea, vomiting, indigestion, or decreased appetite, which are the most common side effects of both medications